News
Crude contracts fell by around $1 heading into Thursday afternoon trade as investors took profits following a three-day gain amid global economic optimism, while the market continued to closely ...
Thursday's stock-market rally has started to ease a bit heading into midday, with the Dow sinking into the red. The pullback accelerated after President Trump announced a 90-day extension of a ...
56m
Investor's Business Daily on MSNStock Market Today: Dow Dips In Mixed Action; Meta, Carvana Build Alternate Entries But Arm Falls 12% (Live Coverage)
The Dow Jones index rose Thursday as it appeared a China trade deal was near. Nvidia partner Arm plunged on earnings.
That analyst, Derek Hernandez of PitchBook Data, also said Figma (FIG) stands out from other companies that have gone public recently as a "generational software-as-a-service company that has achieved ...
Trump’s tariffs and trade deals continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.
Microsoft’s stock is often “a safe place” for investors to be between earnings reports, analysts at Guggenheim Partners said ...
Copper Turns Lower in London Following U.S. Tariff Exemptions Copper prices in London fell after President Trump said the U.S. would impose a 50% tariff on copper products but not on the raw material ...
Nasdaq, S&P 500 hit record highs on Microsoft, Meta buzz; PCE and Trump tariff jabs temper sentiment
Fresh data showed inflation rose a bit more than expected in June. The PCE index, the Fed’s preferred inflation gauge, ...
Microsoft hits $4T valuation, powering S&P 500 and Nasdaq to new records as AI optimism lifts tech-heavy markets.
Big rallies for Microsoft and Facebook’s parent company are helping lead stocks back toward more record highs. The S&P 500 rose 0.7% in early trading Thursday.
Mexican President Claudia Sheinbaum said after a telephone call with President Trump on Thursday that her government was successful in preventing an increase in tariffs. “We avoided the increase in ...
15mon MSN
Bristol Myers Beats Earnings Expectations. It’s Still Optimistic About New Schizophrenia Drug.
Cobenfy is one of the key products Bristol is counting on to take up the slack as patents on three of its top-selling drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results